Keywords: A-T; ataxia-telangiectasia; ATM; ataxia-telangiectasia mutated; CGH; comparative genomic hybridization; GISTIC; Genomic Identification of Significant Targets in Cancer; Gzm; granzyme; PBL; peripheral blood lymphocyte; Prkdc; protein kinase; DNA-activated;